News for Eurofins Scientific SE (ERFSF)

For the first quarter of 2025, the Sequoia Strategy Composite generated a total return of 4.4% 1 net of fees, versus negative 4.3% for the Standard and Poor’s 500 Index.

Eurofins Scientific SE (OTCPK:ERFSF) Q4 2024 Earnings Call Transcript January 30, 2025 9:00 AM ETCompany ParticipantsGilles Martin - Chairman of the Board...

Sequoia Strategy Composite returned 19.8% in 2024 vs. 25.0% for S&P 500. Since June of 2016, Sequoia and S&P 500 have compounded at 11.9% and 14.9%, respectively.

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2024

Insights from the Fourth Quarter of 2024 N-PORT Filing Steven Romick (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2024, p

France stocks higher at close of trade; CAC 40 up 1.00%

France stocks higher at close of trade; CAC 40 up 0.14%

France stocks higher at close of trade; CAC 40 up 0.14%

France stocks lower at close of trade; CAC 40 down 0.72%

Eurofins Agrees to Acquire SYNLAB's Clinical Diagnostics Operations in Spain

Earnings call: Eurofins optimistic despite Q3 softness, aims for long-term growth

France stocks lower at close of trade; CAC 40 down 1.01%

Insight into FPA Crescent Fund's Q3 2024 MovesSteven Romick (Trades, Portfolio), a seasoned portfolio manager at FPA since 1996, recently disclosed his investme

France stocks mixed at close of trade; CAC 40 up 0.85%

Accelerating Growth in the Global DNA Sequencing Market: From USD 12.29 Billion in 2023 to USD 44 Billion by 2031, Driven by a 17.12% CAGR...

France stocks mixed at close of trade; CAC 40 down 1.51%

The Global Genetic Engineering Market Size was Valued at USD 1.35 Billion in 2023 and the Worldwide Genetic Engineering Market Size is Expected to Reach...

The Global Gene Panel Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Gene Panel Market Size is Expected to Reach USD 4.46 Billion by...

Baron International Growth Fund increased in the second quarter of 2024, modestly outperforming its benchmark, the MSCI ACWI ex USA Index. Click here to read the full fund letter.